Cytosorbents Corporation
Hedge Funds Holdings
Last updated:
Cytosorbents Corporation‘s stocks are currently a part of 82 hedge funds’ portfolios, which represents 41.58% of the total amount of its stocks outstanding. This makes up a total of 18.02M shares of Cytosorbents Corporation. Compared to the previous quarter, the number grew by 1.35% or 239.80K shares more. As for the holding position changes, 29.27% (24) of current hedge fund investors increased the number of shares held, 32.93% (27) of current holders sold a part of the shares held, and 21.95% (18) closed the holdings completely. 12 hedge funds are new holders of Cytosorbents Corporation stock in Q1 2022, it is 14.63% of total holders.
Hedge funds holding Cytosorbents (Q2 2017 – Q1 2022)
| Q2 2017 | 30 |
|---|---|
| Q3 2017 | 31 |
| Q4 2017 | 44 |
| Q1 2018 | 49 |
| Q2 2018 | 74 |
| Q3 2018 | 78 |
| Q4 2018 | 83 |
| Q1 2019 | 75 |
| Q2 2019 | 67 |
| Q3 2019 | 67 |
| Q4 2019 | 69 |
| Q1 2020 | 79 |
| Q2 2020 | 88 |
| Q3 2020 | 94 |
| Q4 2020 | 92 |
| Q1 2021 | 92 |
| Q2 2021 | 97 |
| Q3 2021 | 92 |
| Q4 2021 | 89 |
| Q1 2022 | 82 |
Hedge funds changes in Cytosorbents positions (Q2 2017 – Q1 2022)
| Q2 2017 | 4 | 7 | 12 | 8 | -1 |
|---|---|---|---|---|---|
| Q3 2017 | 7 | 8 | 5 | 6 | 5 |
| Q4 2017 | 18 | 16 | 5 | 5 | 0 |
| Q1 2018 | 12 | 21 | 9 | 6 | 1 |
| Q2 2018 | 37 | 19 | 6 | 12 | 0 |
| Q3 2018 | 15 | 27 | 22 | 10 | 4 |
| Q4 2018 | 17 | 25 | 23 | 11 | 7 |
| Q1 2019 | 7 | 26 | 22 | 15 | 5 |
| Q2 2019 | 7 | 25 | 21 | 12 | 2 |
| Q3 2019 | 9 | 23 | 20 | 9 | 6 |
| Q4 2019 | 13 | 22 | 20 | 11 | 3 |
| Q1 2020 | 23 | 24 | 18 | 11 | 3 |
| Q2 2020 | 25 | 36 | 12 | 15 | 0 |
| Q3 2020 | 19 | 37 | 19 | 13 | 6 |
| Q4 2020 | 14 | 32 | 21 | 15 | 10 |
| Q1 2021 | 15 | 29 | 27 | 15 | 6 |
| Q2 2021 | 15 | 25 | 38 | 10 | 9 |
| Q3 2021 | 9 | 31 | 28 | 14 | 10 |
| Q4 2021 | 15 | 28 | 27 | 19 | 0 |
| Q1 2022 | 12 | 24 | 27 | 18 | 1 |
Hedge funds changes in Cytosorbents stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 146,000 | 350,000 |
|---|---|---|
| Q3 2017 | 406,000 | 496,000 |
| Q4 2017 | 484,000 | 462,000 |
| Q1 2018 | 1,048,000 | 468,000 |
| Q2 2018 | 1,308,000 | 436,000 |
| Q3 2018 | 776,000 | 211,000 |
| Q4 2018 | 450,000 | 172,000 |
| Q1 2019 | 247,000 | 216,000 |
| Q2 2019 | 0 | 19,000 |
| Q3 2019 | 8,000 | 177,000 |
| Q4 2019 | 1,000 | 60,000 |
| Q1 2020 | 971,000 | 925,000 |
| Q2 2020 | 2,274,000 | 1,043,000 |
| Q3 2020 | 593,000 | 760,000 |
| Q4 2020 | 665,000 | 613,000 |
| Q1 2021 | 1,301,000 | 2,006,000 |
| Q2 2021 | 1,033,000 | 1,491,000 |
| Q3 2021 | 500,000 | 812,000 |
| Q4 2021 | 314,000 | 77,000 |
| Q1 2022 | 71,000 | 3,000 |